TY - JOUR
T1 - An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus
AU - Teng, Y. K.Onno
AU - Bredewold, Edwin O.W.
AU - Rabelink, Ton J.
AU - Huizinga, Tom W.J.
AU - Eikenboom, H. C.Jeroen
AU - Limper, Maarten
AU - Fritsch-Stork, Ruth D.E.
AU - Bloemenkamp, Kitty W.M.
AU - Sueters, Marieke
N1 - Funding Information:
The work of Y.K.O.T. is supported by the Dutch Kidney Foundation and the Netherlands Organisation for Scientific Research.
Publisher Copyright:
© The Author 2017.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Patients with SLE are often young females of childbearing age and a pregnancy wish in this patient group is common. However, SLE patients are at high risk for adverse pregnancy outcomes that require adequate guidance. It is widely acknowledged that pre-pregnancy counselling is the pivotal first step in the management of SLE patients with a wish to become pregnant. Next, management of these patients is usually multidisciplinary and often requires specific expertise from the different physicians involved. Very recently a EULAR recommendation was published emphasizing the need for adequate preconception counselling and risk stratification. Therefore the present review specifically addresses the issue of pre-pregnancy counselling for SLE patients with an evidence-based approach. The review summarizes data retrieved from recently published, high-quality cohort studies that have contributed to a better understanding and estimation of pregnancy-related risks for SLE patients. The present review categorizes risks from a patient-oriented point of view, that is, the influence of pregnancy on SLE, of SLE on pregnancy, of SLE on the foetus/neonate and of SLE-related medication. Lastly, pre-pregnancy counselling of SLE patients with additional secondary APS is reviewed. Collectively these data can guide clinicians to formulate appropriate preventive strategies and patient-tailored monitoring plans during pre-pregnancy counselling of SLE patients.
AB - Patients with SLE are often young females of childbearing age and a pregnancy wish in this patient group is common. However, SLE patients are at high risk for adverse pregnancy outcomes that require adequate guidance. It is widely acknowledged that pre-pregnancy counselling is the pivotal first step in the management of SLE patients with a wish to become pregnant. Next, management of these patients is usually multidisciplinary and often requires specific expertise from the different physicians involved. Very recently a EULAR recommendation was published emphasizing the need for adequate preconception counselling and risk stratification. Therefore the present review specifically addresses the issue of pre-pregnancy counselling for SLE patients with an evidence-based approach. The review summarizes data retrieved from recently published, high-quality cohort studies that have contributed to a better understanding and estimation of pregnancy-related risks for SLE patients. The present review categorizes risks from a patient-oriented point of view, that is, the influence of pregnancy on SLE, of SLE on pregnancy, of SLE on the foetus/neonate and of SLE-related medication. Lastly, pre-pregnancy counselling of SLE patients with additional secondary APS is reviewed. Collectively these data can guide clinicians to formulate appropriate preventive strategies and patient-tailored monitoring plans during pre-pregnancy counselling of SLE patients.
KW - systemic lupus erythematosus
KW - lupus nephritis
KW - glomerulonephritis
KW - anti-phospholipid syndrome
KW - pregnancy
KW - counselling
KW - neonatal lupus
KW - preconception counselling
KW - Pregnancy
KW - Pregnancy Complications/etiology
KW - Pregnancy Outcome
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=85053128096&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kex374
DO - 10.1093/rheumatology/kex374
M3 - Review article
C2 - 29165607
SN - 1462-0324
VL - 57
SP - 1707
EP - 1720
JO - Rheumatology (Oxford, England)
JF - Rheumatology (Oxford, England)
IS - 10
ER -